Neurocognitive Dysfunction clinical trials at UCSF

1 research study open to eligible people

Showing trials for

  • Transseptal vs Retrograde Aortic Ventricular Entry to Reduce Systemic Emboli

    open to eligible people ages 18 years and up

    This study is a prospective, multicenter, randomized (1:1) controlled comparative effectiveness trial of a transseptal approach to left ventricular ablation compared to a retrograde aortic approach to prevent cerebral emboli and neurocognitive decline in adults with ventricular tachycardia (VT) and/or premature ventricular contractions (PVCs).

    San Francisco, California and other locations

Our lead scientists for Neurocognitive Dysfunction research studies include .

Last updated: